Warning: count(): Parameter must be an array or an object that implements Countable in /home/logicben/public_html/drugtrialsformoney.com/wp-content/plugins/redux-framework/redux-core/inc/classes/class-redux-output.php on line 391

A Study of XmAb®20717 in Subjects With Selected Advanced Solid Tumors

A Study of XmAb®20717 in Subjects With Selected Advanced Solid Tumors
Conditions:   Melanoma;   Breast Carcinoma;   Hepatocellular Carcinoma;   Urothelial Carcinoma;   Squamous Cell Carcinoma of the Head and Neck;   Renal Cell Carcinoma;   Colorectal Carcinoma;   Non-small Cell Lung Carcinoma;   Gastric or Gastroesophageal Junction Adenocarcinoma;   Endometrial Carcinoma;   Mesothelioma;   Neuroendocrine Carcinoma;   Cervical Cancer;   Small Cell Lung Carcinoma;   Squamous Cell Carcinoma of the Anus
Intervention:   Biological: XmAb20717
Sponsors:   Xencor, Inc.;   ICON plc
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

October 18, 2019 / by / in
Comments